Archives: Projects/Publication

Prevalence of refractive error in Europe: the European Eye Epidemiology (E3) Consortium

Williams, K., Verhoeven, V., Cumberland, P., Bertelsen, G., Wolfram, C., Buitendijk, G., Hofman, A., Duijn, C., Vingerling, J., Kuijpers, R., Höhn, R., Mirshahi, A., Khawaja, A., Luben, R., Erke, M., Hanno, T., Mahroo, O., Hogg, R., Gieger, C., Cougnard-Grégoire, A., Anastasopoulos, E., Bron, A., Dartigues, J., Korobelnik, J., Creuzot-Garcher, C., Topouzis, F., Delcourt, C., Rahi, J., Meitinger, T., Fletcher, A., Foster, P., Pfeiffer, N., Klaver, C., Hammond, C.

European Journal of Epidemiology DOI: 10.1007/s 10654-015-0010-0

2015

Microaneurysm turnover in the macula is a biomarker for the development of clinically significant macular edema in diabetes type 2

Ribeiro L.; Nunes S.; Cunha-Vaz J.

Current Biomarker Findings 2013:3 11-15

2013

Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy.

Ribeiro, M.L., Nunes, S.G., Cunha-Vaz, J.

DIABETES CARE 2013, DOI:10.2337/DC12–1491

2013

Macular Thickness Measured by Stratus OCT in patients with Diabetes Type 2 and Mild Nonproliferative Retinopathy without Clinical evidence of Macular Edema.

Pires I.; Santos, A.; Nunes S.; Lobo C.

Ophthalmologica 2013; 229(4):181-186.

2013

Three Different Phenotypes of Mild Nonproliferative Diabetic Retinopathy with Different Risks for Development of Clinically Significant Macular Edema

Nunes S.; Ribeiro L.; Fonseca M.; Cunha-Vaz J.

DOI: 10.1167/iovs.13-11895

2013

Subclinical Macular Edema as a predictor of progression to Clinically Significant Macular Edema in Diabetes type 2

Pires, I., Santos, A., Nunes, S., Lobo, C., Cunha-Vaz, J.

Ophthalmologica 230(4):201-6, 2013

2013

Choroidal thickness after treatment for myopic choroidal neovascularization

Farinha, C.L., Baltar, A.S., Nunes, S.G., Franqueira, N.F., Figueira, J.P., Pires, I.A., Cachulo, M.L., Silva, R.M.

Eur J Ophthalmol 2013 Jun 13:0; DOI: 10,5301/ejo.5000323

2013

Degree of Decrease in Central Retinal Thickness Predicts Visual Acuity Response to Intravitreal Ranibizumab in Diabetic Macular Edema

Santos A.R., Gomes S.C., Figueira J., Nunes S., Lobo C.L., Cunha-Vaz J.G.

Ophthalmologica 2013; DOI: 10.1159/000355487

2013

Biomarkers of Diabetic Retinopathy

Cunha-Vaz J, Ribeiro L, Nunes S, Lobo C.

Diabetes Manage 2014; 4(2), 181-192

2014

Degree of decrease in central retinal thickness predicts visual acuity response to intravitreal ranibizumab in diabetic macular edema.

Santos AR; Gomes SC; Figueira J; Nunes S; Lobo CL; Cunha-Vaz JG

Ophthalmologica. 2014;231(1):16-22.

2014

Neurodegeneration in the diabetic Eye: new insights and terapeutic perspectives.

Simó R; Hernández C; European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR); Collaborators (17).

Trends Endocrinol Metab. 20104 Jan; 25(1):23-33. Epub 2013

2014